479 related articles for article (PubMed ID: 14625623)
1. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemic events in subjects with atherosclerosis in the coronary or cerebral arteries.
Galan P; de Bree A; Mennen L; Potier de Courcy G; Preziozi P; Bertrais S; Castetbon K; Hercberg S
J Nutr Health Aging; 2003; 7(6):428-35. PubMed ID: 14625623
[TBL] [Abstract][Full Text] [Related]
2. B vitamin and/or ω-3 fatty acid supplementation and cancer: ancillary findings from the supplementation with folate, vitamins B6 and B12, and/or omega-3 fatty acids (SU.FOL.OM3) randomized trial.
Andreeva VA; Touvier M; Kesse-Guyot E; Julia C; Galan P; Hercberg S
Arch Intern Med; 2012 Apr; 172(7):540-7. PubMed ID: 22331983
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases.
de Bree A; Mennen LI; Hercberg S; Galan P
Eur J Clin Nutr; 2004 May; 58(5):732-44. PubMed ID: 15116076
[TBL] [Abstract][Full Text] [Related]
4. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Clarke R; Armitage J
Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
[TBL] [Abstract][Full Text] [Related]
5. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
Wolters M; Hermann S; Hahn A
Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
[TBL] [Abstract][Full Text] [Related]
6. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
Lee BJ; Huang MC; Chung LJ; Cheng CH; Lin KL; Su KH; Huang YC
Eur J Clin Nutr; 2004 Mar; 58(3):481-7. PubMed ID: 14985687
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine lowering and cardiovascular events after acute myocardial infarction.
Bønaa KH; Njølstad I; Ueland PM; Schirmer H; Tverdal A; Steigen T; Wang H; Nordrehaug JE; Arnesen E; Rasmussen K;
N Engl J Med; 2006 Apr; 354(15):1578-88. PubMed ID: 16531614
[TBL] [Abstract][Full Text] [Related]
9. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
10. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function.
Van Guelpen B; Hultdin J; Johansson I; Witthöft C; Weinehall L; Eliasson M; Hallmans G; Palmqvist R; Jansson JH; Winkvist A
J Intern Med; 2009 Aug; 266(2):182-95. PubMed ID: 19298497
[TBL] [Abstract][Full Text] [Related]
11. Vitamins and stroke: the homocysteine hypothesis still in doubt.
Ntaios GC; Savopoulos CG; Chatzinikolaou AC; Kaiafa GD; Hatzitolios A
Neurologist; 2008 Jan; 14(1):2-4. PubMed ID: 18195649
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of milk enriched with omega-3 polyunsaturated fatty acids, oleic acid, folic acid, and vitamins E and B6 in volunteers with mild hyperlipidemia.
Carrero JJ; Baró L; Fonollá J; González-Santiago M; Martínez-Férez A; Castillo R; Jiménez J; Boza JJ; López-Huertas E
Nutrition; 2004 Jun; 20(6):521-7. PubMed ID: 15165614
[TBL] [Abstract][Full Text] [Related]
13. [Does diet affect our mood? The significance of folic acid and homocysteine].
Karakuła H; Opolska A; Kowal A; Domański M; Płotka A; Perzyński J
Pol Merkur Lekarski; 2009 Feb; 26(152):136-41. PubMed ID: 19388520
[TBL] [Abstract][Full Text] [Related]
14. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
Booth GL; Wang EE
CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design for the CARDIOVIT Study (Cardiovit, Atherosclerotic vascular disease and hypeRhomocysteinemia: an epiDemiological study in Indians, additionally evaluating the effect of Oral VITamin supplementation).
Shenoy KT; Lena KB; Sali N; Syam S; Shenoy ST; Rajadhyaksha VD; Pai GP; Shaikh AA;
Curr Med Res Opin; 2006 Apr; 22(4):641-8. PubMed ID: 16684424
[TBL] [Abstract][Full Text] [Related]
16. Control of baseline cardiovascular risk factors in the SU-FOL-OM3 study cohort: does the localization of the arterial event matter?
Vesin C; Galan P; Gautier B; Czernichow S; Hercberg S; Blacher J
Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):541-8. PubMed ID: 20216318
[TBL] [Abstract][Full Text] [Related]
17. The China Stroke Secondary Prevention Trial (CSSPT) protocol: a double-blinded, randomized, controlled trial of combined folic acid and B vitamins for secondary prevention of stroke.
Liu X; Shi M; Xia F; Han J; Liu Z; Wang B; Yang F; Li L; Wu S; Wang L; Liu N; Lv Y; Zhao G
Int J Stroke; 2015 Feb; 10(2):264-8. PubMed ID: 23490255
[TBL] [Abstract][Full Text] [Related]
18. Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial.
Andreeva VA; Kesse-Guyot E; Barberger-Gateau P; Fezeu L; Hercberg S; Galan P
Am J Clin Nutr; 2011 Jul; 94(1):278-86. PubMed ID: 21593490
[TBL] [Abstract][Full Text] [Related]
19. Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease.
de Lau LM; Koudstaal PJ; Witteman JC; Hofman A; Breteler MM
Neurology; 2006 Jul; 67(2):315-8. PubMed ID: 16864826
[TBL] [Abstract][Full Text] [Related]
20. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.
Toole JF; Malinow MR; Chambless LE; Spence JD; Pettigrew LC; Howard VJ; Sides EG; Wang CH; Stampfer M
JAMA; 2004 Feb; 291(5):565-75. PubMed ID: 14762035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
